World's Best Scientists 2026 revealed!
Award Badge
Microbiology
USA
2026

D-Index & Metrics

Microbiology

D-Index
129
Citations
73505
World Ranking
80
National Ranking
40

Medicine

D-Index
130
Citations
74110
World Ranking
2463
National Ranking
1392

Research.com Recognitions

  • 2026 - Research.com Microbiology in United States Leader Award
  • 2025 - Research.com Microbiology in United States Leader Award

Overview

Joseph J. Eron is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research primarily focuses on the field of Medicine, with a particular emphasis on Infectious Diseases, Virology, Emergency Medicine, Epidemiology, and Immunology.

The scientist's work centers mainly on HIV/AIDS research and related interventions. Specific topics within this area include HIV research and treatment, HIV/AIDS drug development and treatment, and HIV-related health complications and treatments. In addition to HIV-focused research, Joseph J. Eron also investigates SARS-CoV-2 and COVID-19, including clinical research studies related to COVID-19 and its impact.

Frequent publication venues for Joseph J. Eron's work include:

  • UNC Libraries
  • The Journal of Infectious Diseases
  • Open Forum Infectious Diseases
  • AIDS
  • Clinical Infectious Diseases

Frequent co-authors collaborating with Joseph J. Eron consist of:

  • Richard D. Moore
  • Sonia Napravnik
  • Mari M. Kitahata
  • Michael S. Saag
  • David A. Wohl

Recent notable publications include:

  • Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women, 2021, New England Journal of Medicine
  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults, 2022, JAMA
  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults, 2020, JAMA
  • A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus, 2021, Science Translational Medicine
  • Molnupiravir, an Oral Antiviral Treatment for COVID-19, 2021, bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Prevention of HIV-1 Infection with Early Antiretroviral Therapy

    Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble

  • A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

    Scott M. Hammer;Kathleen E. Squires;Michael D. Hughes;Michael D. Hughes;Janet M. Grimes

  • Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

    R M Gulick;J W Mellors;D Havlir;J J Eron

  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy

  • Antiretroviral Therapy for the Prevention of HIV-1 Transmission

    Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble

  • Effect of early versus deferred antiretroviral therapy for HIV on survival.

    Mari M. Kitahata;Stephen J. Gange;Alison G. Abraham;Barry Merriman

  • Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

    N. M. Archin;A. L. Liberty;A. D. Kashuba;S. K. Choudhary

  • Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.

    Jacob P. Lalezari;Keith Henry;Mary O'Hearn;Julio S.G. Montaner

  • Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1

    Myron S Cohen;Irving F Hoffman;Rachel A Royce;Peter Kazembe

  • Brief but efficient: acute HIV infection and the sexual transmission of HIV.

    Christopher D. Pilcher;Hsiao Chuan Tien;Joseph J. Eron;Pietro L. Vernazza

  • Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

    Georgia D. Tomaras;Nicole L. Yates;Pinghuang Liu;Li Qin

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F. Günthard;Michael S. Saag;Constance A. Benson;Carlos del Rio

  • Antiretroviral Treatment of Adult HIV Infection

    Scott M. Hammer;Joseph J. Eron;Peter Reiss;Robert T. Schooley

  • Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

    Raphael J Landovitz;Deborah Donnell;Meredith E Clement;Brett Hanscom

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel

    Michael S. Saag;Constance A. Benson;Rajesh T. Gandhi;Jennifer F. Hoy

  • Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter

    Joseph J. Eron;Sharon L. Benoit;Joseph Jemsek;Rodger David MacArthur

  • Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

    Beatriz Grinsztejn;Mina C. Hosseinipour;Heather J. Ribaudo;Susan Swindells

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.

    Unknown

  • A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

    Unknown

  • Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

    David A. Margolis;Juan Gonzalez-Garcia;Hans Jürgen Stellbrink;Joseph J. Eron

  • Detection of acute infections during HIV testing in North Carolina.

    Christopher D. Pilcher;Susan A. Fiscus;Trang Q. Nguyen;Evelyn Foust

  • The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

    Joseph Eron;Patrick Yeni;Joseph Gathe;Vicente Estrada

Frequent Co-Authors

Richard D. Moore
Richard D. Moore Johns Hopkins University
Mari M. Kitahata
Mari M. Kitahata University of Washington
Michael S. Saag
Michael S. Saag University of Alabama at Birmingham
Myron S. Cohen
Myron S. Cohen University of North Carolina at Chapel Hill
Susan A. Fiscus
Susan A. Fiscus University of North Carolina at Chapel Hill
Ronald J. Bosch
Ronald J. Bosch Harvard University
Michael J. Mugavero
Michael J. Mugavero University of Alabama at Birmingham
Stephen R. Cole
Stephen R. Cole University of North Carolina at Chapel Hill
Kenneth H. Mayer
Kenneth H. Mayer Harvard Medical School
William C. Miller
William C. Miller The Ohio State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology opens up numerous career opportunities, often enhanced by pursuing related online degrees. For those interested in healthcare, exploring online healthcare programs can provide flexible options for further specialization while balancing work and study.

Public health is a natural extension of microbiology, especially in disease prevention and epidemiology. Accredited online MPH programs are an efficient way to advance your knowledge; some of the easiest to get into are detailed in accredited online mph programs easy to get into.

Another related career path involves working closely with children in healthcare settings. Becoming a certified child life specialist often requires CCLS certification, which is thoroughly explained in this guide on ccls certification.

For individuals with a felony record, continuing education and career growth in microbiology and related fields is still possible. Many universities offer supportive options listed under degrees for felons, allowing you to pursue your academic and professional goals without barriers.

Best Scientists Citing Joseph J. Eron

Trending Scientists

Recently Published Articles